BRAND_ANALYSIS #NOVO_NORDISK HEALTH & PHARMA #8 OF 26 IN HEALTH & PHARMA INTERESTING

Novo Nordisk

· Public · Updated 23 Aug 2026 07:27 UTC
#289 of 1208 overall by tension · #8 of 26 in Health & Pharma
18 Interesting
The Silent Giant
Analysis

Ozempic's cultural explosion hasn't budged Novo Nordisk's relevance score (55). The paradox: you own the zeitgeist but the brand remains pharma-anonymous. Stock bleeding (-1.75%), sentiment flat (0.40).

IN THE NEWS (100 articles this week)
Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills - WSJ
Novo begins study to find lowest effective dose for Wegovy pill - Reuters
Pursuing patient options, Novo kicks off trial testing smaller doses of Wegovy pill - Fierce Pharma
Cultural Score
55 / 100
Business Score
73 / 100
TREND
TENSION▂▃▂▂▂▁▂▂▁▁▁▂▂▂
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▇▆▆▆▅▆▆▅▅▅▅▆▆
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 40/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 16/30
Market Position 22/25
Revenue Growth 15/25
Earnings Health 20/20
STOCK DATA
Price$46.74
30d Change-1.8%
Market Cap$206.7B
Profit Margin35.4%
BRANDS LIKE THIS
Moderna
C:50 B:67 T:17
Nomura
C:55 B:73 T:18
John Deere
C:57 B:75 T:18
Caterpillar
C:55 B:74 T:19
FedEx
C:55 B:72 T:17
SHARE
Novo Nordisk's tension is 18. Commerce outpacing culture. sociologyofcapitalism.com/brand/novo-nordisk
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/novo-nordisk.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman